Navigation Links
Patients' health service use
Date:12/10/2012

Primary care physicians Johannes Hauswaldt, Eva Hummers-Pradier, and Ulrike Junius-Walker address the question of how frequently different patient groups attend doctor's appointments in this issue of Deutsches rzteblatt International (Dtsch Arztebl Int 2012; 109[47]: 81420).

Current estimates for Germany are of 18 doctor's appointments per patient per year. However, until now there has been no further information on, for example, age groups or whether frequent contact with doctors is particularly noticeable in particular patient groups.

The authors defined patient groups, such as those with chronic illnesses, those with multiple illnesses, and frequent attenders. They then analyzed anonymized data for a total of 305 896 patients at 155 primary care practices from 1996 to 2006.

Each patient saw his or her primary care physician an average of seven times per year. Contrary to expectations, those with chronic illnesses did not see their doctors more frequently, but they did require special medical services such as detailed consultations and home visits. Frequent attenders seem to be a problematic group in outpatient care. They had an average of 24 doctorpatient contacts per year, although they were not seriously ill.


'/>"/>

Contact: Johannes Hauswaldt
Johannes.Hauswaldt@med.uni-goettingen.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Gaps in Care Found for Sickle Cell Disease Patients
2. Reduced intensity regimen prior to marrow transplant better for older leukemia patients
3. Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
4. More than a third of high-risk leukemia patients respond to an experimental new drug
5. Dr. Michael Reiss of Southern Nevada Chiropractic Helps Car Accident Patients with Neck or Back Pain by Providing Computerized Spinal Exam and a Copy of His Book
6. Studies challenge standards to improve treatment outcomes for patients with clotting disorders
7. Investigational agent targets gene signaling pathways to improve response for patients with CLL
8. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
9. VABC Responds to Study on Use of Cholesterol Lowering Drug Statins on Cancer Patients
10. Dr. Michael Reiss is Helping to Reduce Neck and Back Pain in Las Vegas and is Now Welcoming New Patients
11. Existing drugs may help more breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 18, 2017 , ... A ... information and contact points to easily connect elderly veterans of America's armed forces ... elder-care funding. It also conveys material on this year's increase in the Veterans ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network offers physicians ... controlled and non-controlled substances plus the ability to manage orders on their desktop ... now accept electronic prescriptions, according to the Office of the National Coordinator of ...
(Date:2/17/2017)... ... 17, 2017 , ... Corrective Action & Preventive Action for ... Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/capamd      ... action (PA)? , The methods share techniques and tools but they are different ...
(Date:2/17/2017)... ... 17, 2017 , ... MAP Revenue Cycle Solutions (MAP RCS), ... been promoted to Chief Executive Officer. , The need for maximizing reimbursements ... that demands the transition from pay-for-service to pay-for-performance models. By delivering efficient and ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the nation, Onslow ... part by the Hospital Readmission Reduction Program (HRRP), the return of a patient to ... hospitals across the nation. While many providers are struggling to leverage limited resources and ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... , Feb. 19, 2017  nThrive™, an ... cycle portfolio and thought leadership at the 2017 ... a category leader award from KLAS. ... discussion focused on how market trends shape the ... particularly a sophisticated, comprehensive Patient Access solution. The ...
(Date:2/18/2017)... , Feb. 17, 2017  Pharmaceutical companies have long ... products either in development or already on the market.   ... the pharma industry to alter how it manages advisory board ... leader Best Practices, LLC conducted a new study focused on ... ...
(Date:2/17/2017)... , Feb. 17, 2017 Theravance ... Biopharma" or the "Company") today announced the presentation ... potent, and orally administered pan-Janus kinase (JAK) inhibitor ... th Congress of the European Crohn,s and ... Company reported further data from its completed Phase ...
Breaking Medicine Technology: